CSols, Inc. Enhances and Extends GenoLogics Clarity LIMS for Adaptive Biotechnologies
May 19 2017 - 02:15PM
Business Wire
CSols, Inc. the premier Laboratory Informatics consultancy,
announced the successful completion of the enhancement and
extension of GenoLogics Clarity Lab Information Management System
(LIMS) for Adaptive Biotechnologies, the leader in high-throughput
immunosequencing. To make use of several new features, and to
further automate the processing and management of its assays,
Adaptive Biotechnologies decided to upgrade its GenoLogics Clarity
LIMS. In scoping the requirements for this upgrade, Adaptive
Biotechnologies realized that some enhancements, extensions, and
interfaces (instruments and systems) were needed, and turned to
CSols, a Clarity Certified Application Development (CCAD) partner,
for assistance.
Adaptive engaged CSols to develop the enhancements, extensions,
and interfaces, because of CSols’ expertise with Clarity LIMS, the
Clarity LIMS API, and its laboratory and domain knowledge.
“CSols was fantastic to work with,” said Sean Nolan, chief
technology officer of Adaptive Biotechnologies. “Their consultants
were exactly what we needed.”
The project was completed successfully, on time and within
budget. Consequently, Adaptive Biotechnologies was able to realize
many benefits including:
- Increased usability, functionality,
quality, and productivity by leveraging CSols Clarity LIMS API and
domain expertise to facilitate the upgrade of GenoLogics Clarity
LIMS
- Increased levels of automation and
integration yielding greater efficiency and laboratory
throughput
- Attained a high level of system
adoption and utilization through the tailoring of functionality to
fit Adaptive’s needs, without altering current work processes and
methods
The full Project Case Study can be downloaded here.
About CSols, Inc.
CSols, Inc. is the premier Laboratory Informatics Consultancy,
providing objective guidance and tailored solutions through their
services: strategic planning and vendor selection, implementation
and enhancement, and computer system validation. For more
information, visit www.csolsinc.com.
About Adaptive Biotechnologies®
Adaptive Biotechnologies is the pioneer and leader in combining
high-throughput sequencing and expert bioinformatics to profile
T-cell and B-cell receptors. Adaptive is bringing the accuracy and
sensitivity of its immunosequencing platform into laboratories
around the world to drive groundbreaking research in cancer and
other immune-mediated diseases. Adaptive also translates
immunosequencing discoveries into clinical diagnostics and
therapeutic development to improve patient care. For more
information, visit adaptivebiotech.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170519005694/en/
CSols, Inc.Megan Cavanaugh, 302-731-5290